MXPA03004687A - Derivados de indol y dihidroindol. - Google Patents

Derivados de indol y dihidroindol.

Info

Publication number
MXPA03004687A
MXPA03004687A MXPA03004687A MXPA03004687A MXPA03004687A MX PA03004687 A MXPA03004687 A MX PA03004687A MX PA03004687 A MXPA03004687 A MX PA03004687A MX PA03004687 A MXPA03004687 A MX PA03004687A MX PA03004687 A MXPA03004687 A MX PA03004687A
Authority
MX
Mexico
Prior art keywords
indole
dihydroindole derivatives
dihydroindole
derivatives
Prior art date
Application number
MXPA03004687A
Other languages
English (en)
Inventor
Thomas Weller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03004687A publication Critical patent/MXPA03004687A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
MXPA03004687A 2000-11-28 2001-11-21 Derivados de indol y dihidroindol. MXPA03004687A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125955 2000-11-28
PCT/EP2001/013553 WO2002044149A1 (en) 2000-11-28 2001-11-21 Indole and dihydroindole derivatives

Publications (1)

Publication Number Publication Date
MXPA03004687A true MXPA03004687A (es) 2003-09-05

Family

ID=8170500

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004687A MXPA03004687A (es) 2000-11-28 2001-11-21 Derivados de indol y dihidroindol.

Country Status (15)

Country Link
US (1) US6503907B2 (es)
EP (1) EP1349833B1 (es)
JP (1) JP4068457B2 (es)
KR (1) KR100523888B1 (es)
CN (2) CN1245385C (es)
AR (1) AR034186A1 (es)
AT (1) ATE323675T1 (es)
AU (2) AU2002224870B2 (es)
BR (1) BR0115618A (es)
CA (1) CA2428315C (es)
DE (1) DE60118970T2 (es)
ES (1) ES2261518T3 (es)
MX (1) MXPA03004687A (es)
WO (1) WO2002044149A1 (es)
ZA (1) ZA200303689B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075931A2 (en) * 2005-12-22 2007-07-05 Biosite Incorporated Reactive heterocyclic derivatives and methods for their synthesis and use
FR2913016B1 (fr) * 2007-02-23 2009-04-24 Cerep Sa Derives d'indole, benzimidazole ou benzotriazole, comprenant un noyau piperidine ou piperazine, comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
CN106749074A (zh) * 2016-11-14 2017-05-31 沈阳药科大学 一种联芳基噁唑烷酮中间体的制备方法
TWI748194B (zh) 2018-06-28 2021-12-01 德商菲尼克斯 Ｆｘｒ有限責任公司 含有雙環核心部分之新穎lxr調節劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
JPH0764841B2 (ja) * 1990-10-03 1995-07-12 ファイザー製薬株式会社 インドール誘導体およびその用途
TW438774B (en) 1993-07-14 2001-06-07 Hoffmann La Roche Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines
US6313127B1 (en) * 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
US5958965A (en) * 1996-08-27 1999-09-28 American Home Products Corporation 4-aminoethoxy indoles
GB9919411D0 (en) * 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
KR20030051880A (ko) 2003-06-25
AR034186A1 (es) 2004-02-04
CN1733723A (zh) 2006-02-15
ATE323675T1 (de) 2006-05-15
DE60118970T2 (de) 2007-04-12
DE60118970D1 (de) 2006-05-24
AU2002224870B2 (en) 2007-06-21
JP2004520291A (ja) 2004-07-08
US6503907B2 (en) 2003-01-07
KR100523888B1 (ko) 2005-10-26
BR0115618A (pt) 2003-09-16
AU2487002A (en) 2002-06-11
CN1476432A (zh) 2004-02-18
CA2428315A1 (en) 2002-06-06
ZA200303689B (en) 2004-08-13
CA2428315C (en) 2009-02-17
US20020103247A1 (en) 2002-08-01
JP4068457B2 (ja) 2008-03-26
ES2261518T3 (es) 2006-11-16
EP1349833B1 (en) 2006-04-19
CN1245385C (zh) 2006-03-15
EP1349833A1 (en) 2003-10-08
WO2002044149A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
MXPA02005101A (es) Derivados de indol canabimimeticos.
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
HK1041885A1 (en) Amide derivatives.
HK1051037A1 (en) Benzodiazepine derivatives.
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
ZA200203003B (en) N-substituted carbamoyloxyalkyl-azolium derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1051863A1 (en) Indol-3-yl derivatives.
HK1037619A1 (en) Indole derivatives.
ZA991590B (en) Indole derivatives and pharmaceutical compositions comprising the same.
AU8664701A (en) Oxindole derivatives
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
MXPA01012041A (es) Derivados de indol.
GB9825988D0 (en) Indole derivatives
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
HK1049161A1 (en) Indole derivatives.
MXPA03005395A (es) Derivados de dihidroindol y tetrahidroquinolina.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
AU2002219176A1 (en) Dihydroindole and tetrahydroquinoline derivatives
MXPA03004687A (es) Derivados de indol y dihidroindol.
MXPA01011285A (es) Derivados de tio-oxindol.

Legal Events

Date Code Title Description
FG Grant or registration